Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds DA Davidson Downgrades Okta to Neutral

DA Davidson Downgrades Okta to Neutral

DA Davidson analyst Rudy Kessinger downgrades Okta (NASDAQ:OKTA) from Buy to Neutral.

byBenzinga Newsdesk

August 10, 2022

1 minute read

DA Davidson analyst Rudy Kessinger downgrades Okta (NASDAQ:OKTA) from Buy to Neutral.

Analyst Ratings

10 Analysts Have This to Say About Scotts Miracle Gro

By Benzinga Insights

April 26, 4:00 PM

Analysts have provided the following ratings for Scotts Miracle Gro (NYSE:SMG) within the last quarter: Bullish Somewhat Bullish…

SMG

Pot Giant Denies Using Political Influence To Regain Its New Jersey Cannabis License In Record Time

By Nina Zdinjak

June 2, 11:07 AM

Cannabis giant Curaleaf (OTCQX: CURLF) is suspected of using its political connections to reverse an April decision by the NJ Cann

CURLF

Nuvation Bio Doses First Patient In Phase 1b Combination Study Of NUV-868

By Benzinga Newsdesk

December 19, 5:08 PM

Phase 1b study designed to determine the safety and dose of NUV-868 in combination with olaparib or enzalutamide for the treatment of advanced solid tumors Nuvation Bio Inc. (NYSE:NUVB), a biopharmaceutical company

NUVB

NIO, BYD Receive Beijing’s Approval For Autonomous Driving Tests Amid Tesla’s FSD Launch Aspirations In China

By Benzinga Neuro

June 5, 9:04 AM

However, they must first conduct test and safety evaluations before actual road testing can commence.

BYDDF

DA Davidson Downgrades Okta to Neutral

Related Posts

10 Analysts Have This to Say About Scotts Miracle Gro

Pot Giant Denies Using Political Influence To Regain Its New Jersey Cannabis License In Record Time

Nuvation Bio Doses First Patient In Phase 1b Combination Study Of NUV-868

NIO, BYD Receive Beijing’s Approval For Autonomous Driving Tests Amid Tesla’s FSD Launch Aspirations In China